The UW/FHCRC CFAR recompeted in 2002, received a score of 130, and was refunded at $1.5M per year 3/1/03. Our 2002 application requested $2.5M per year for core budgets for years 2-5 contingent on raising the CFAR funding Cap. Our CFAR is now eligible for base award funding up to $3M per year beginning 2004. This application thus contains (1) our 2002 application with the proposed core enhancements and new services and related budget requests for years 2-5 now highlighted in bold italics; (2) a new summary of these enhancements, new services and related budget requests at the front of the CFAR Research Plan, together with each core's responses to core-specific concerns expressed in the 2002 review Summary Statement; and (3) two proposed new CFAR Scientific Programs. OAR lists 163 HIV/AIDS awards to the UW, FHCRC, and affiliates from NIH in FY02 for $111,301,211 (134 awards for $91,449,746 were """"""""allowable"""""""" up from $9.1M in 1988 and $25.9M in 1997 and $79.4M in 2001). Strategic planning for HIV/AIDS program development has resulted in 180,000 sq. ft. of new or renovated space since 1997 for CFAR members at the UW, FHCRC, and affiliated institutions. Our CFAR has 249 members and 66 trainees. This application includes 10 funded Cores: A) Administration, B) Development, C) Biostatistics; D) Clinical Research, which will collaborate with other cores to establish an HIV Specimen Repository Subcore; and will sponsor pilot grants for use of this repository and of the Core G clinical data base; E) International Research, which will begin a new Subcore for HIV/AIDS research and research training in Women and Children; F) Clinical Retrovirology; G) Health Services Research; H) Genomics, supports new microarray and bioinformatics research; I) Molecular Immunology, which will add BIACORE facilities for studying HIV envelope interactions with antibodies and receptors; and J) SocioBehavioral and Prevention Research, a new core, added to support increasing numbers of behavioral and prevention research projects at the UW. Two new CFAR Scientific Programs are proposed: Program 1, Mathematical Modeling for HIV/STD Research, includes the new component project: Multilevel Intervention Strategies for HIV Prevention: Mathematical Modeling for Efficacy Trials. Program 2, HIV-1 Research in Women, includes the new component project: HIV-1 Pathogenesis and Treatment in Women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027757-17S3
Application #
6764543
Study Section
Special Emphasis Panel (ZAI1-AR-A (J3))
Program Officer
Namkung, Ann S
Project Start
1997-03-01
Project End
2008-02-29
Budget Start
2004-04-01
Budget End
2005-02-28
Support Year
17
Fiscal Year
2004
Total Cost
$1,348,837
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pankau, Mark D; Wamalwa, Dalton; Benki-Nugent, Sarah et al. (2018) Decay of HIV DNA in the Reservoir and the Impact of Short Treatment Interruption in Kenyan Infants. Open Forum Infect Dis 5:ofx268
Dombrowski, Julia C; Hughes, James P; Buskin, Susan E et al. (2018) A Cluster Randomized Evaluation of a Health Department Data to Care Intervention Designed to Increase Engagement in HIV Care and Antiretroviral Use. Sex Transm Dis 45:361-367
Pyra, Maria; Haberer, Jessica E; Heffron, Renee et al. (2018) Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships. J Acquir Immune Defic Syndr 77:41-45
Luethy, Paul M; Murphy, Sean C; Seilie, Annette M et al. (2018) Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease. Malar J 17:23
Pyra, Maria; Lingappa, Jairam R; Heffron, Renee et al. (2018) Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women. Contraception 97:357-362
LaCourse, Sylvia M; Pavlinac, Patricia B; Cranmer, Lisa M et al. (2018) Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS 32:69-78
Wagner, Anjuli D; Wilson, Kate S; Babigumira, Joseph B et al. (2018) Can Adolescents and Young Adults in Kenya Afford Free HIV Testing Services? J Assoc Nurses AIDS Care :
Riddler, Sharon A; Zheng, Lu; Durand, Christine M et al. (2018) Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART. Open Forum Infect Dis 5:ofy242
Coghill, Anna E; Schenk, Jeannette M; Mahkoul, Zeina et al. (2018) Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda. AIDS 32:505-512
Olwit, Connie; Mugaba, Maureen; Osingada, Charles Peter et al. (2018) Existence, triggers, and coping with chronic sorrow: a qualitative study of caretakers of children with sickle cell disease in a National Referral Hospital in Kampala, Uganda. BMC Psychol 6:50

Showing the most recent 10 out of 1275 publications